Table 1.
Antibacterial effect on Staphylococcus aureus (S. aureus), Escherichia coli (E. coli), Klebsiella pneumonia (K. pneumonia) and Bacillus subtilis (B. subtilis) for low, medium and high doses of gold nanoparticles (NPs) of two sizes, sample named as G1 and G2.
| Strain | (%) Reduction in Growth Sample G1 of Gold NPs | (%) Reduction in Growth Sample G2 of Gold NPs | ||||
|---|---|---|---|---|---|---|
| (% + Standard Error) | (% + Standard Error) | |||||
| Low Dose 1.35 μg/mL | Medium Dose 2.03 μg/mL | High Dose 2.7 μg/mL | Low Dose 1.35 μg/mL | Medium Dose 2.03 μg/mL | High Dose 2.7 μg/mL | |
| Staphylococcus aureus | 46.4 ± 0.4 | 33.75 ± 1.2 | 22.4 ± 0.8 | 53.1 ± 0.6 | 40 ± 1.3 | 23.7 ± 0.8 |
| Escherichia coli | 45.2 ± 1.4 | 26.6 ± 0.8 | 4.2 ± 0.9 | 47.6 ± 1.3 | 32.2 ± 0.8 | 6.2 ± 0.9 |
| Klebsiella pneumonia | 38.3 ± 0.2 | 22.8 ± 0.3 | 10.0 ± 0.2 | 42.7 ± 0.3 | 26.8 ± 0.1 | 13.8 ± 0.2 |
| Bacillus Subtilis | 57.8 ± 0.2 | 52.1 ± 0.1 | 45.2 ± 0.2 | 60.7 ± 0.2 | 56.3 ± 0.1 | 49.4 ± 0.2 |